Verastem reported $72.77M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
AstraZeneca AZN:LN 35932M 408M
Curis CRIS:US $ 62.04M 13.93M
Cytokinetics CYTK:US $ 111.41M 4.85M
Epizyme EPZM:US $ 11.12M 31.81M
Gilead Sciences GILD:US $ 20215M 288M
Immunogen IMGN:US $ 249.83M 56.64M
Laboratory Of America LH:US $ 10400.7M 320.4M
Novartis NOVN:VX SF 62925M 1385M
Tg Therapeutics TGTX:US $ 170.39M 66.77M
Verastem VSTM:US $ 72.77M 14.79M
YTE INCY:US $ 4085.06M 221.99M
Ziopharm Oncology ZIOP:US $ 49.12M 8.94M